[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Artificial Cardiopulmonary Machine Market, Global Outlook and Forecast 2022-2028

March 2022 | 75 pages | ID: AA391E6B5EA2EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Artificial Cardiopulmonary Machine in global, including the following market information:

Global Artificial Cardiopulmonary Machine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Artificial Cardiopulmonary Machine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Artificial Cardiopulmonary Machine companies in 2021 (%)

The global Artificial Cardiopulmonary Machine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single Roller Pump HLM Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Artificial Cardiopulmonary Machine include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica and Tianjin Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Cardiopulmonary Machine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Artificial Cardiopulmonary Machine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Artificial Cardiopulmonary Machine Market Segment Percentages, by Type, 2021 (%)
  • Single Roller Pump HLM
  • Double Roller Pump HLM
Global Artificial Cardiopulmonary Machine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Artificial Cardiopulmonary Machine Market Segment Percentages, by Application, 2021 (%)
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Global Artificial Cardiopulmonary Machine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Artificial Cardiopulmonary Machine Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Artificial Cardiopulmonary Machine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Artificial Cardiopulmonary Machine revenues share in global market, 2021 (%)

Key companies Artificial Cardiopulmonary Machine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Artificial Cardiopulmonary Machine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • LivaNova (Sorin)
  • Getinge (Maquet)
  • Medtronic
  • Terumo CV Group
  • Braile Biomedica
  • Tianjin Medical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Artificial Cardiopulmonary Machine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Artificial Cardiopulmonary Machine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ARTIFICIAL CARDIOPULMONARY MACHINE OVERALL MARKET SIZE

2.1 Global Artificial Cardiopulmonary Machine Market Size: 2021 VS 2028
2.2 Global Artificial Cardiopulmonary Machine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Artificial Cardiopulmonary Machine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Artificial Cardiopulmonary Machine Players in Global Market
3.2 Top Global Artificial Cardiopulmonary Machine Companies Ranked by Revenue
3.3 Global Artificial Cardiopulmonary Machine Revenue by Companies
3.4 Global Artificial Cardiopulmonary Machine Sales by Companies
3.5 Global Artificial Cardiopulmonary Machine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Artificial Cardiopulmonary Machine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Artificial Cardiopulmonary Machine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Artificial Cardiopulmonary Machine Players in Global Market
  3.8.1 List of Global Tier 1 Artificial Cardiopulmonary Machine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Artificial Cardiopulmonary Machine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Artificial Cardiopulmonary Machine Market Size Markets, 2021 & 2028
  4.1.2 Single Roller Pump HLM
  4.1.3 Double Roller Pump HLM
4.2 By Type - Global Artificial Cardiopulmonary Machine Revenue & Forecasts
  4.2.1 By Type - Global Artificial Cardiopulmonary Machine Revenue, 2017-2022
  4.2.2 By Type - Global Artificial Cardiopulmonary Machine Revenue, 2023-2028
  4.2.3 By Type - Global Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
4.3 By Type - Global Artificial Cardiopulmonary Machine Sales & Forecasts
  4.3.1 By Type - Global Artificial Cardiopulmonary Machine Sales, 2017-2022
  4.3.2 By Type - Global Artificial Cardiopulmonary Machine Sales, 2023-2028
  4.3.3 By Type - Global Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
4.4 By Type - Global Artificial Cardiopulmonary Machine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Artificial Cardiopulmonary Machine Market Size, 2021 & 2028
  5.1.2 Cardiac Surgery
  5.1.3 Lung Transplant Operation
  5.1.4 Acute Respiratory Failure Treatment
  5.1.5 Others
5.2 By Application - Global Artificial Cardiopulmonary Machine Revenue & Forecasts
  5.2.1 By Application - Global Artificial Cardiopulmonary Machine Revenue, 2017-2022
  5.2.2 By Application - Global Artificial Cardiopulmonary Machine Revenue, 2023-2028
  5.2.3 By Application - Global Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
5.3 By Application - Global Artificial Cardiopulmonary Machine Sales & Forecasts
  5.3.1 By Application - Global Artificial Cardiopulmonary Machine Sales, 2017-2022
  5.3.2 By Application - Global Artificial Cardiopulmonary Machine Sales, 2023-2028
  5.3.3 By Application - Global Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
5.4 By Application - Global Artificial Cardiopulmonary Machine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Artificial Cardiopulmonary Machine Market Size, 2021 & 2028
6.2 By Region - Global Artificial Cardiopulmonary Machine Revenue & Forecasts
  6.2.1 By Region - Global Artificial Cardiopulmonary Machine Revenue, 2017-2022
  6.2.2 By Region - Global Artificial Cardiopulmonary Machine Revenue, 2023-2028
  6.2.3 By Region - Global Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
6.3 By Region - Global Artificial Cardiopulmonary Machine Sales & Forecasts
  6.3.1 By Region - Global Artificial Cardiopulmonary Machine Sales, 2017-2022
  6.3.2 By Region - Global Artificial Cardiopulmonary Machine Sales, 2023-2028
  6.3.3 By Region - Global Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Artificial Cardiopulmonary Machine Revenue, 2017-2028
  6.4.2 By Country - North America Artificial Cardiopulmonary Machine Sales, 2017-2028
  6.4.3 US Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.4.4 Canada Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.4.5 Mexico Artificial Cardiopulmonary Machine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Artificial Cardiopulmonary Machine Revenue, 2017-2028
  6.5.2 By Country - Europe Artificial Cardiopulmonary Machine Sales, 2017-2028
  6.5.3 Germany Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.5.4 France Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.5.5 U.K. Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.5.6 Italy Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.5.7 Russia Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.5.8 Nordic Countries Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.5.9 Benelux Artificial Cardiopulmonary Machine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Artificial Cardiopulmonary Machine Revenue, 2017-2028
  6.6.2 By Region - Asia Artificial Cardiopulmonary Machine Sales, 2017-2028
  6.6.3 China Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.6.4 Japan Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.6.5 South Korea Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.6.6 Southeast Asia Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.6.7 India Artificial Cardiopulmonary Machine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Artificial Cardiopulmonary Machine Revenue, 2017-2028
  6.7.2 By Country - South America Artificial Cardiopulmonary Machine Sales, 2017-2028
  6.7.3 Brazil Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.7.4 Argentina Artificial Cardiopulmonary Machine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Artificial Cardiopulmonary Machine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Artificial Cardiopulmonary Machine Sales, 2017-2028
  6.8.3 Turkey Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.8.4 Israel Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.8.5 Saudi Arabia Artificial Cardiopulmonary Machine Market Size, 2017-2028
  6.8.6 UAE Artificial Cardiopulmonary Machine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 LivaNova (Sorin)
  7.1.1 LivaNova (Sorin) Corporate Summary
  7.1.2 LivaNova (Sorin) Business Overview
  7.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Major Product Offerings
  7.1.4 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales and Revenue in Global (2017-2022)
  7.1.5 LivaNova (Sorin) Key News
7.2 Getinge (Maquet)
  7.2.1 Getinge (Maquet) Corporate Summary
  7.2.2 Getinge (Maquet) Business Overview
  7.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Major Product Offerings
  7.2.4 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales and Revenue in Global (2017-2022)
  7.2.5 Getinge (Maquet) Key News
7.3 Medtronic
  7.3.1 Medtronic Corporate Summary
  7.3.2 Medtronic Business Overview
  7.3.3 Medtronic Artificial Cardiopulmonary Machine Major Product Offerings
  7.3.4 Medtronic Artificial Cardiopulmonary Machine Sales and Revenue in Global (2017-2022)
  7.3.5 Medtronic Key News
7.4 Terumo CV Group
  7.4.1 Terumo CV Group Corporate Summary
  7.4.2 Terumo CV Group Business Overview
  7.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Major Product Offerings
  7.4.4 Terumo CV Group Artificial Cardiopulmonary Machine Sales and Revenue in Global (2017-2022)
  7.4.5 Terumo CV Group Key News
7.5 Braile Biomedica
  7.5.1 Braile Biomedica Corporate Summary
  7.5.2 Braile Biomedica Business Overview
  7.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Major Product Offerings
  7.5.4 Braile Biomedica Artificial Cardiopulmonary Machine Sales and Revenue in Global (2017-2022)
  7.5.5 Braile Biomedica Key News
7.6 Tianjin Medical
  7.6.1 Tianjin Medical Corporate Summary
  7.6.2 Tianjin Medical Business Overview
  7.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Major Product Offerings
  7.6.4 Tianjin Medical Artificial Cardiopulmonary Machine Sales and Revenue in Global (2017-2022)
  7.6.5 Tianjin Medical Key News

8 GLOBAL ARTIFICIAL CARDIOPULMONARY MACHINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Artificial Cardiopulmonary Machine Production Capacity, 2017-2028
8.2 Artificial Cardiopulmonary Machine Production Capacity of Key Manufacturers in Global Market
8.3 Global Artificial Cardiopulmonary Machine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ARTIFICIAL CARDIOPULMONARY MACHINE SUPPLY CHAIN ANALYSIS

10.1 Artificial Cardiopulmonary Machine Industry Value Chain
10.2 Artificial Cardiopulmonary Machine Upstream Market
10.3 Artificial Cardiopulmonary Machine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Artificial Cardiopulmonary Machine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Artificial Cardiopulmonary Machine in Global Market
Table 2. Top Artificial Cardiopulmonary Machine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Artificial Cardiopulmonary Machine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Artificial Cardiopulmonary Machine Revenue Share by Companies, 2017-2022
Table 5. Global Artificial Cardiopulmonary Machine Sales by Companies, (K Units), 2017-2022
Table 6. Global Artificial Cardiopulmonary Machine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Artificial Cardiopulmonary Machine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Artificial Cardiopulmonary Machine Product Type
Table 9. List of Global Tier 1 Artificial Cardiopulmonary Machine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Cardiopulmonary Machine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Artificial Cardiopulmonary Machine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Artificial Cardiopulmonary Machine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Artificial Cardiopulmonary Machine Sales (K Units), 2017-2022
Table 15. By Type - Global Artificial Cardiopulmonary Machine Sales (K Units), 2023-2028
Table 16. By Application – Global Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Artificial Cardiopulmonary Machine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Artificial Cardiopulmonary Machine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Artificial Cardiopulmonary Machine Sales (K Units), 2017-2022
Table 20. By Application - Global Artificial Cardiopulmonary Machine Sales (K Units), 2023-2028
Table 21. By Region – Global Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Artificial Cardiopulmonary Machine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Artificial Cardiopulmonary Machine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Artificial Cardiopulmonary Machine Sales (K Units), 2017-2022
Table 25. By Region - Global Artificial Cardiopulmonary Machine Sales (K Units), 2023-2028
Table 26. By Country - North America Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Artificial Cardiopulmonary Machine Sales, (K Units), 2017-2022
Table 29. By Country - North America Artificial Cardiopulmonary Machine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Artificial Cardiopulmonary Machine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Artificial Cardiopulmonary Machine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Artificial Cardiopulmonary Machine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Artificial Cardiopulmonary Machine Sales, (K Units), 2023-2028
Table 38. By Country - South America Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Artificial Cardiopulmonary Machine Sales, (K Units), 2017-2022
Table 41. By Country - South America Artificial Cardiopulmonary Machine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Artificial Cardiopulmonary Machine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Artificial Cardiopulmonary Machine Sales, (K Units), 2023-2028
Table 46. LivaNova (Sorin) Corporate Summary
Table 47. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Offerings
Table 48. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Getinge (Maquet) Corporate Summary
Table 50. Getinge (Maquet) Artificial Cardiopulmonary Machine Product Offerings
Table 51. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Medtronic Corporate Summary
Table 53. Medtronic Artificial Cardiopulmonary Machine Product Offerings
Table 54. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Terumo CV Group Corporate Summary
Table 56. Terumo CV Group Artificial Cardiopulmonary Machine Product Offerings
Table 57. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Braile Biomedica Corporate Summary
Table 59. Braile Biomedica Artificial Cardiopulmonary Machine Product Offerings
Table 60. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Tianjin Medical Corporate Summary
Table 62. Tianjin Medical Artificial Cardiopulmonary Machine Product Offerings
Table 63. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Artificial Cardiopulmonary Machine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Artificial Cardiopulmonary Machine Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Artificial Cardiopulmonary Machine Production by Region, 2017-2022 (K Units)
Table 67. Global Artificial Cardiopulmonary Machine Production by Region, 2023-2028 (K Units)
Table 68. Artificial Cardiopulmonary Machine Market Opportunities & Trends in Global Market
Table 69. Artificial Cardiopulmonary Machine Market Drivers in Global Market
Table 70. Artificial Cardiopulmonary Machine Market Restraints in Global Market
Table 71. Artificial Cardiopulmonary Machine Raw Materials
Table 72. Artificial Cardiopulmonary Machine Raw Materials Suppliers in Global Market
Table 73. Typical Artificial Cardiopulmonary Machine Downstream
Table 74. Artificial Cardiopulmonary Machine Downstream Clients in Global Market
Table 75. Artificial Cardiopulmonary Machine Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Artificial Cardiopulmonary Machine Segment by Type
Figure 2. Artificial Cardiopulmonary Machine Segment by Application
Figure 3. Global Artificial Cardiopulmonary Machine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Artificial Cardiopulmonary Machine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Artificial Cardiopulmonary Machine Revenue, 2017-2028 (US$, Mn)
Figure 7. Artificial Cardiopulmonary Machine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Artificial Cardiopulmonary Machine Revenue in 2021
Figure 9. By Type - Global Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 10. By Type - Global Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Artificial Cardiopulmonary Machine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 13. By Application - Global Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Artificial Cardiopulmonary Machine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 16. By Region - Global Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 19. US Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 24. Germany Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 25. France Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 33. China Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 37. India Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 40. Brazil Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share, 2017-2028
Figure 44. Turkey Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Artificial Cardiopulmonary Machine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Artificial Cardiopulmonary Machine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Artificial Cardiopulmonary Machine by Region, 2021 VS 2028
Figure 50. Artificial Cardiopulmonary Machine Industry Value Chain
Figure 51. Marketing Channels


More Publications